Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypersensitivity Reaction

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    August 2017
  1. SIMPSON EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, et al
    When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
    J Am Acad Dermatol. 2017 Aug 10. pii: S0190-9622(17)31944.
    PubMed     Text format     Abstract available


    July 2017
  2. ABROUK M, Farahnik B, Zhu TH, Nakamura M, et al
    Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses.
    J Am Acad Dermatol. 2017;77:177-180.
    PubMed     Text format    


    June 2017
  3. ECKERT L, Gupta S, Amand C, Gadkari A, et al
    Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: An analysis using the National Health and Wellness Survey.
    J Am Acad Dermatol. 2017 Jun 9. pii: S0190-9622(17)30506.
    PubMed     Text format     Abstract available


  4. THYSSEN JP, Toft PB, Halling-Overgaard AS, Gislason GH, et al
    Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis.
    J Am Acad Dermatol. 2017 Jun 7. pii: S0190-9622(17)30360.
    PubMed     Text format     Abstract available


  5. SHAHWAN KT, Kimball AB
    Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis.
    J Am Acad Dermatol. 2017;76:1198-1200.
    PubMed     Text format    


  6. CORCIMARU A, Morrell DS, Burkhart CN
    The Internet for patient education on atopic dermatitis: Friend or foe?
    J Am Acad Dermatol. 2017;76:1197-1198.
    PubMed     Text format    


    May 2017
  7. SILVERBERG JI, Simpson EL
    Reply to: "Heterogeneity of data included in meta-analysis on persistence of atopic dermatitis alters interpretation".
    J Am Acad Dermatol. 2017;76:e183-e184.
    PubMed     Text format    


  8. MARGOLIS DJ, Mitra N
    Heterogeneity of data included in meta-analysis on persistence of atopic dermatitis changes interpretation.
    J Am Acad Dermatol. 2017;76:e181.
    PubMed     Text format    


  9. SILVERBERG JI, Simpson EL
    Reply to: "Conclusions about atopic dermatitis persistence might be premature".
    J Am Acad Dermatol. 2017;76:e179.
    PubMed     Text format    


  10. ABUABARA K, Langan SM, Yu AM
    Conclusions about atopic dermatitis persistence might be premature.
    J Am Acad Dermatol. 2017;76:e177-e178.
    PubMed     Text format    


  11. RAMIREZ F, Chren MM, Botto N
    A review of the impact of patch testing on quality of life in allergic contact dermatitis.
    J Am Acad Dermatol. 2017;76:1000-1004.
    PubMed     Text format    


  12. HSU DY, Brieva J, Silverberg NB, Paller AS, et al
    Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.
    J Am Acad Dermatol. 2017;76:811-817.
    PubMed     Text format     Abstract available


  13. LARSABAL M, Marti A, Jacquemin C, Rambert J, et al
    Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies are clinically and biologically distinct from vitiligo.
    J Am Acad Dermatol. 2017;76:863-870.
    PubMed     Text format     Abstract available


    April 2017
  14. THYSSEN JP, Skov L, Hamann CR, Gislason GH, et al
    Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index.
    J Am Acad Dermatol. 2017 Apr 6. pii: S0190-9622(17)30123.
    PubMed     Text format     Abstract available


  15. HAMANN CR, Hamann D, Egeberg A, Johansen JD, et al
    Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2017 Apr 6. pii: S0190-9622(17)30152.
    PubMed     Text format     Abstract available


  16. SHREBERK-HASSIDIM R, Ramot Y, Zlotogorski A
    Janus kinase inhibitors in dermatology: A systematic review.
    J Am Acad Dermatol. 2017;76:745-753.
    PubMed     Text format     Abstract available


  17. DAMSKY W, King BA
    JAK inhibitors in dermatology: The promise of a new drug class.
    J Am Acad Dermatol. 2017;76:736-744.
    PubMed     Text format     Abstract available


    March 2017
  18. MOHAMMAD AA, Wu SZ, Ibrahim O, Bena J, et al
    Prevalence of atopic comorbidities in eosinophilic esophagitis: A case-control study of 449 patients.
    J Am Acad Dermatol. 2017;76:559-560.
    PubMed     Text format    


    February 2017
  19. BROWN G, Wang E, Leon A, Huynh M, et al
    Tumor necrosis factor-alpha inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience.
    J Am Acad Dermatol. 2017;76:334-341.
    PubMed     Text format     Abstract available


    January 2017
  20. KIM M, Choi KH, Hwang SW, Lee YB, et al
    Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study.
    J Am Acad Dermatol. 2017;76:40-48.
    PubMed     Text format     Abstract available


  21. LEE HY, Fook-Chong S, Koh HY, Thirumoorthy T, et al
    Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.
    J Am Acad Dermatol. 2017;76:106-113.
    PubMed     Text format     Abstract available


    December 2016
  22. SAUDER MB, McEvoy A, Ramien ML
    Prescribing success: Developing an integrated prescription and eczema action plan for atopic dermatitis.
    J Am Acad Dermatol. 2016;75:1281-1283.
    PubMed     Text format    


  23. VAN DER SCHAFT J, Ariens LF, Bruijnzeel-Koomen CA, de Bruin-Weller MS, et al
    Serum vitamin D status in adult patients with atopic dermatitis: Recommendations for daily practice.
    J Am Acad Dermatol. 2016;75:1257-1259.
    PubMed     Text format    


    November 2016
  24. TOTRI CR, Eichenfield LF, Logan K, Proudfoot L, et al
    Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    J Am Acad Dermatol. 2016 Nov 14. pii: S0190-9622(16)30832.
    PubMed     Text format     Abstract available


  25. FARAHNIK B, Beroukhim K, Danesh M, Nakamura M, et al
    Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study.
    J Am Acad Dermatol. 2016;75:1068-1071.
    PubMed     Text format    


  26. FARAHNIK B, Kwong B, Murase J
    General management strategy for epidermal growth factor receptor inhibitor-associated papulopustular eruption.
    J Am Acad Dermatol. 2016;75:e191.
    PubMed     Text format    


  27. DEZA G, Brasileiro A, Bertolin-Colilla M, Curto-Barredo L, et al
    Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort.
    J Am Acad Dermatol. 2016;75:918-924.
    PubMed     Text format     Abstract available


  28. PERRY BM, Nguyen A, Desmond BL, Blattner CM, et al
    Eruptive nevi associated with medications (ENAMs).
    J Am Acad Dermatol. 2016;75:1045-1052.
    PubMed     Text format     Abstract available


    October 2016
  29. WEISS D, Schaschinger M, Ristl R, Gruber R, et al
    Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression.
    J Am Acad Dermatol. 2016 Oct 13. pii: S0190-9622(16)30599.
    PubMed     Text format     Abstract available


  30. ANDERSEN YM, Egeberg A, Gislason GH, Skov L, et al
    Autoimmune diseases in adults with atopic dermatitis.
    J Am Acad Dermatol. 2016 Oct 11. pii: S0190-9622(16)30734.
    PubMed     Text format     Abstract available


  31. EGEBERG A, Skov L, Andersen YM, Mallbris L, et al
    Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasis.
    J Am Acad Dermatol. 2016 Oct 11. pii: S0190-9622(16)30399.
    PubMed     Text format     Abstract available


    September 2016
  32. HILL MK, Kheirandish Pishkenari A, Braunberger TL, Armstrong AW, et al
    Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review.
    J Am Acad Dermatol. 2016 Sep 8. pii: S0190-9622(16)30474.
    PubMed     Text format     Abstract available


  33. HAN B, Wu WH, Bae JM, Son SJ, et al
    Serum leptin and adiponectin levels in atopic dermatitis (AD) and their relation to disease severity.
    J Am Acad Dermatol. 2016;75:629-31.
    PubMed     Text format    


  34. GONZALEZ ME, Schaffer JV, Orlow SJ, Gao Z, et al
    Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.
    J Am Acad Dermatol. 2016;75:481-493.
    PubMed     Text format     Abstract available


    August 2016
  35. KIM JP, Chao LX, Simpson EL, Silverberg JI, et al
    Persistence of atopic dermatitis (AD): A systematic review and meta-analysis.
    J Am Acad Dermatol. 2016 Aug 17. pii: S0190-9622(16)30309.
    PubMed     Text format     Abstract available


  36. KANTOR R, Kim A, Thyssen J, Silverberg JI, et al
    Association of atopic dermatitis with smoking: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2016 Aug 16. pii: S0190-9622(16)30495.
    PubMed     Text format     Abstract available


  37. BARBAROT S, Rogers NK, Abuabara K, Aubert H, et al
    Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.
    J Am Acad Dermatol. 2016 Aug 10. pii: S0190-9622(16)30325.
    PubMed     Text format     Abstract available


  38. MINKIS K, Whittington A, Alam M
    Dermatologic surgery emergencies: Complications caused by systemic reactions, high-energy systems, and trauma.
    J Am Acad Dermatol. 2016;75:265-84.
    PubMed     Text format     Abstract available


    July 2016
  39. HANIFIN JM
    New drugs for atopic dermatitis may provide clues to basic mechanisms of itch and inflammation.
    J Am Acad Dermatol. 2016 Jul 7. pii: S0190-9622(16)30390.
    PubMed     Text format    


  40. PALLER AS, Tom WL, Lebwohl MG, Blumenthal RL, et al
    Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
    J Am Acad Dermatol. 2016 Jul 7. pii: S0190-9622(16)30330.
    PubMed     Text format     Abstract available


  41. WEI EX, Kirsner RS, Eaglstein WH
    End points in dermatologic clinical trials: A review for clinicians.
    J Am Acad Dermatol. 2016;75:203-9.
    PubMed     Text format     Abstract available


    June 2016
  42. KOHLI N, Nedorost S
    Inflamed skin predisposes to sensitization to less potent allergens.
    J Am Acad Dermatol. 2016 Jun 8. pii: S0190-9622(16)01548.
    PubMed     Text format     Abstract available


  43. SIMPSON EL, Gadkari A, Worm M, Soong W, et al
    Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
    J Am Acad Dermatol. 2016 Jun 4. pii: S0190-9622(16)30193.
    PubMed     Text format     Abstract available


  44. CHEN YC, Rosenblum MD, Shinkai K
    Plasmacytoid dendritic cells (pDCs) and regulatory T (Treg) cells may be the key to viral reactivation in drug-induced hypersensitivity syndrome (DIHS).
    J Am Acad Dermatol. 2016;74:1288-9.
    PubMed     Text format    


  45. MOWAD CM, Anderson B, Scheinman P, Pootongkam S, et al
    Allergic contact dermatitis: Patient management and education.
    J Am Acad Dermatol. 2016;74:1043-54.
    PubMed     Text format     Abstract available


  46. MOWAD CM, Anderson B, Scheinman P, Pootongkam S, et al
    Allergic contact dermatitis: Patient diagnosis and evaluation.
    J Am Acad Dermatol. 2016;74:1029-40.
    PubMed     Text format     Abstract available


  47. CLARK JJ, Secrest AM, Hull CM, Eliason MJ, et al
    The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review.
    J Am Acad Dermatol. 2016;74:1274-6.
    PubMed     Text format    


  48. FAIVRE C, Villani AP, Aubin F, Lipsker D, et al
    Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
    J Am Acad Dermatol. 2016;74:1153-9.
    PubMed     Text format     Abstract available


  49. MOON AT, Castelo-Soccio L, Yan AC
    Emergency department utilization of pediatric dermatology (PD) consultations.
    J Am Acad Dermatol. 2016;74:1173-7.
    PubMed     Text format     Abstract available


    May 2016
  50. KOHN LL, Kang Y, Antaya RJ
    A randomized, controlled trial comparing topical steroid application to wet versus dry skin in children with atopic dermatitis (AD).
    J Am Acad Dermatol. 2016 May 31. pii: S0190-9622(16)30199.
    PubMed     Text format     Abstract available


  51. HANIFIN JM, Ellis CN, Frieden IJ, Folster-Holst R, et al
    OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study.
    J Am Acad Dermatol. 2016 May 14. pii: S0190-9622(16)30025.
    PubMed     Text format     Abstract available


  52. BROEDERS JA, Ahmed Ali U, Fischer G
    Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience.
    J Am Acad Dermatol. 2016 May 11. pii: S0190-9622(16)01495.
    PubMed     Text format     Abstract available


    March 2016
  53. AUBIN F, Avenel-Audran M, Jeanmougin M, Adamski H, et al
    Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.
    J Am Acad Dermatol. 2016;74:574-5.
    PubMed     Text format    


    February 2016
  54. ERRICHETTI E, Pegolo E, Stinco G
    Dermoscopy as an auxiliary tool in the early differential diagnosis of acute generalized exanthematous pustulosis (AGEP) and exanthematous (morbilliform) drug eruption.
    J Am Acad Dermatol. 2016;74:e29-31.
    PubMed     Text format    


  55. CURTIS JA, Christensen LC, Paine AR, Collins Brummer G, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis treatments: An Internet survey.
    J Am Acad Dermatol. 2016;74:379-80.
    PubMed     Text format    


  56. PASCOE VL, Fenves AZ, Wofford J, Jackson JM, et al
    The spectrum of nephrocutaneous diseases and associations: Inflammatory and medication-related nephrocutaneous associations.
    J Am Acad Dermatol. 2016;74:247-70.
    PubMed     Text format     Abstract available


    January 2016
  57. HWANG SJ, Carlos G, Wakade D, Byth K, et al
    Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.
    J Am Acad Dermatol. 2016 Jan 12. pii: S0190-9622(15)02387.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: